Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Morrow

Showing results (221-230 of 237) with videos related to

Pageof 24
Sort By:
Nature Communications|February 12, 2025
DNA immunotherapy for recurrent respiratory papillomatosis (RRP): phase 1/2 study assessing efficacy, safety, and immunogenicity of INO-3107Matthew P Morrow, Elisabeth Gillespie, Albert Sylvester, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 29, 2026
A Phase Ib, Placebo-controlled Randomized Clinical Trial of the Ebolavirus DNA Vaccine Candidate INO-4201 Followed by Electroporation as Booster Vaccination in Healthy, rVSVΔG-ZEBOV-GP-primed Volunteers (Boost-EBOV)Angela Huttner, Marc-Antoine de La Vega, Cristina Boehm-Bosmani, et al.
Infection and Immunity|July 31, 2013
Inducing humoral and cellular responses to multiple sporozoite and liver-stage malaria antigens using exogenous plasmid DNAB Ferraro, K T Talbott, A Balakrishnan, et al.
Critical Pathways in Cardiology|April 24, 2020
Restructuring Electrophysiology During the COVID-19 Pandemic: A Practical Guide From a New York City Hospital NetworkGeoffrey A Rubin, Elaine Y Wan, Deepak Saluja, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 26, 2020
CD8<sup>+</sup> T Cells Impact Rising PSA in Biochemically Relapsed Cancer Patients Using Immunotherapy Targeting Tumor-Associated AntigensNeal D Shore, Matthew P Morrow, Trevor McMullan, et al.
Lancet (London, England)|September 21, 2015
Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trialCornelia L Trimble, Matthew P Morrow, Kimberly A Kraynyak, et al.
Frontiers in Immunology|November 10, 2025
Safety, tolerability, and immunogenicity of INO-4500, a synthetic DNA-based vaccine against Lassa virus, in a phase 1b clinical trial in healthy Ghanaian adultsKwadwo Ansah Koram, Kathleen A Walker, Bonaventure Orizu, et al.
Nature Cardiovascular Research|November 25, 2022
Rad regulation of Ca<sub>V</sub>1.2 channels controls cardiac fight-or-flight responseArianne Papa, Sergey I Zakharov, Alexander N Katchman, et al.
Nature Communications|July 15, 2026
Uncovering an alternate pathway of antibiotic resistance in spore-forming bacteriaYogitha N Srikhanta, Clara E Bate, Desirel Ng, et al.
Journal of the American Heart Association|November 10, 2020
Admission Cardiac Diagnostic Testing with Electrocardiography and Troponin Measurement Prognosticates Increased 30-Day Mortality in COVID-19Timothy J Poterucha, Pierre Elias, Sneha S Jain, et al.
Pageof 24

Showing results (221-230 of 237) with videos related to

Sort By:
Pageof 24
Nature Communications|February 12, 2025
DNA immunotherapy for recurrent respiratory papillomatosis (RRP): phase 1/2 study assessing efficacy, safety, and immunogenicity of INO-3107Matthew P Morrow, Elisabeth Gillespie, Albert Sylvester, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 29, 2026
A Phase Ib, Placebo-controlled Randomized Clinical Trial of the Ebolavirus DNA Vaccine Candidate INO-4201 Followed by Electroporation as Booster Vaccination in Healthy, rVSVΔG-ZEBOV-GP-primed Volunteers (Boost-EBOV)Angela Huttner, Marc-Antoine de La Vega, Cristina Boehm-Bosmani, et al.
Infection and Immunity|July 31, 2013
Inducing humoral and cellular responses to multiple sporozoite and liver-stage malaria antigens using exogenous plasmid DNAB Ferraro, K T Talbott, A Balakrishnan, et al.
Critical Pathways in Cardiology|April 24, 2020
Restructuring Electrophysiology During the COVID-19 Pandemic: A Practical Guide From a New York City Hospital NetworkGeoffrey A Rubin, Elaine Y Wan, Deepak Saluja, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 26, 2020
CD8<sup>+</sup> T Cells Impact Rising PSA in Biochemically Relapsed Cancer Patients Using Immunotherapy Targeting Tumor-Associated AntigensNeal D Shore, Matthew P Morrow, Trevor McMullan, et al.
Lancet (London, England)|September 21, 2015
Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trialCornelia L Trimble, Matthew P Morrow, Kimberly A Kraynyak, et al.
Frontiers in Immunology|November 10, 2025
Safety, tolerability, and immunogenicity of INO-4500, a synthetic DNA-based vaccine against Lassa virus, in a phase 1b clinical trial in healthy Ghanaian adultsKwadwo Ansah Koram, Kathleen A Walker, Bonaventure Orizu, et al.
Nature Cardiovascular Research|November 25, 2022
Rad regulation of Ca<sub>V</sub>1.2 channels controls cardiac fight-or-flight responseArianne Papa, Sergey I Zakharov, Alexander N Katchman, et al.
Nature Communications|July 15, 2026
Uncovering an alternate pathway of antibiotic resistance in spore-forming bacteriaYogitha N Srikhanta, Clara E Bate, Desirel Ng, et al.
Journal of the American Heart Association|November 10, 2020
Admission Cardiac Diagnostic Testing with Electrocardiography and Troponin Measurement Prognosticates Increased 30-Day Mortality in COVID-19Timothy J Poterucha, Pierre Elias, Sneha S Jain, et al.
Pageof 24